InMed stock rallied yesterday on a merger announcement with Mentari Therapeutics. Here’s why the transaction is concerning ...
Shares of InMed Pharmaceuticals INM surged 36.33% at market close after the company announced the launch of its neurodegenerative disease program (INM-900 series), to investigate the effects of ...
IPDNProfessional Diversity Network, Inc. NDEVNovus Acquisition & Development Corp. LFSWFLifeist Wellness Inc. BLMHBlum Holdings, Inc. InMed Pharmaceuticals Inc., a clinical stage pharmaceutical ...
InMed Pharmaceuticals Inc. (NASDAQ:INM) stock is surging early Tuesday, with a session volume of 6.63 million compared to the average volume of 1.31 million, as per data from Benzinga Pro. On Tuesday, ...
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the manufacturing, development and commercialization of ...
We’ll send you a myFT Daily Digest email rounding up the latest Paul Connolly news every morning. Independent News & Media has accused Paul Connolly, a non-executive director of the company, of making ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
View InMed Pharmaceuticals Inc. INM stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results